These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 30783071)

  • 21. Pathophysiology of negative symptom dimensions of schizophrenia - Current developments and implications for treatment.
    Bègue I; Kaiser S; Kirschner M
    Neurosci Biobehav Rev; 2020 Sep; 116():74-88. PubMed ID: 32533996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations.
    Leentjens AF; Dujardin K; Marsh L; Martinez-Martin P; Richard IH; Starkstein SE; Weintraub D; Sampaio C; Poewe W; Rascol O; Stebbins GT; Goetz CG
    Mov Disord; 2008 Oct; 23(14):2004-14. PubMed ID: 18709683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting Predischarge Anhedonia Among Inpatients With Schizophrenia and Schizoaffective Disorders: A Large-scale Analysis.
    Ritsner MS; Ratner Y
    J Nerv Ment Dis; 2019 Jan; 207(1):12-21. PubMed ID: 30575703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating the empirical support for therapeutic targets proposed by the temporal experience of pleasure model in schizophrenia: A systematic review.
    Edwards CJ; Cella M; Tarrier N; Wykes T
    Schizophr Res; 2015 Oct; 168(1-2):120-44. PubMed ID: 26342966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switch, a new intervention that targets motivational negative symptoms in people with schizophrenia: An uncontrolled pilot study.
    Thonon B; Levaux MN; Della Libera C; Larøi F
    J Clin Psychol; 2020 Oct; 76(10):1797-1806. PubMed ID: 32453892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Evaluation of an Online Training Platform for Teaching Positive Emotions for People With Schizophrenia.
    Nguyen A; Frobert L; Kollbrunner A; Favrod J
    Front Psychiatry; 2022; 13():798019. PubMed ID: 35197875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two and five-factor models of negative symptoms in schizophrenia are differentially associated with trait affect, defeatist performance beliefs, and psychosocial functioning.
    Paul NB; Strauss GP; Gates-Woodyatt JJ; Barchard KA; Allen DN
    Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1715-1724. PubMed ID: 36633673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consummatory and anticipatory anhedonia in schizophrenia: stability, and associations with emotional distress and social function over six months.
    Buck B; Lysaker PH
    Psychiatry Res; 2013 Jan; 205(1-2):30-5. PubMed ID: 23021909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anhedonia and negative symptomatology in chronic schizophrenia.
    Loas G; Boyer P; Legrand A
    Compr Psychiatry; 1996; 37(1):5-11. PubMed ID: 8770519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of negative and depressive symptoms: Discriminatory relevance of affect and expression.
    Richter J; Hölz L; Hesse K; Wildgruber D; Klingberg S
    Eur Psychiatry; 2019 Jan; 55():23-28. PubMed ID: 30384108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms.
    Llerena K; Park SG; McCarthy JM; Couture SM; Bennett ME; Blanchard JJ
    Compr Psychiatry; 2013 Jul; 54(5):568-74. PubMed ID: 23351831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
    Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of PRIME, a Mobile App Intervention Designed to Improve Motivation in Young People With Schizophrenia.
    Schlosser DA; Campellone TR; Truong B; Etter K; Vergani S; Komaiko K; Vinogradov S
    Schizophr Bull; 2018 Aug; 44(5):1010-1020. PubMed ID: 29939367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing concepts in negative symptoms: primary vs secondary and apathy vs expression.
    Kirkpatrick B
    J Clin Psychiatry; 2014; 75 Suppl 1():3-7. PubMed ID: 24581452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Social affiliation and negative symptoms in schizophrenia: Examining the role of behavioral skills and subjective responding.
    Blanchard JJ; Park SG; Catalano LT; Bennett ME
    Schizophr Res; 2015 Oct; 168(1-2):491-7. PubMed ID: 26235753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-pleasure beliefs in patients with schizophrenia and individuals with social anhedonia.
    Yang Y; Yang ZY; Zou YM; Shi HS; Wang Y; Xie DJ; Zhang RT; Lui SSY; Cohen AC; Strauss GP; Cheung EFC; Chan RCK
    Schizophr Res; 2018 Nov; 201():137-144. PubMed ID: 29804927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profiling of experiential pleasure, emotional regulation and emotion expression in patients with schizophrenia.
    Zou YM; Ni K; Yang ZY; Li Y; Cai XL; Xie DJ; Zhang RT; Zhou FC; Li WX; Lui SSY; Shum DHK; Cheung EFC; Chan RCK
    Schizophr Res; 2018 May; 195():396-401. PubMed ID: 28869096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of long-term institutionalization on experiential pleasure and motivation in patients with schizophrenia.
    Chu MY; Hu HX; Ni H; Lu WH; Lui SSY; Yi ZH; Cheung EFC; Chan RCK
    Psych J; 2020 Feb; 9(1):77-86. PubMed ID: 31328448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Add-On Pregnenolone with L-Theanine to Antipsychotic Therapy Relieves Negative and Anxiety Symptoms of Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Kardashev A; Ratner Y; Ritsner MS
    Clin Schizophr Relat Psychoses; 2018; 12(1):31-41. PubMed ID: 26218236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.
    Kring AM; Gur RE; Blanchard JJ; Horan WP; Reise SP
    Am J Psychiatry; 2013 Feb; 170(2):165-72. PubMed ID: 23377637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.